What are the guidelines for managing acute ischemic and hemorrhagic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Stroke Management

Initial Assessment and Imaging

All patients with suspected stroke must undergo immediate non-contrast CT scan to differentiate ischemic from hemorrhagic stroke before initiating any treatment, with a target door-to-needle time of less than 60 minutes. 1, 2

  • Perform CT angiography immediately after non-contrast CT in patients presenting within 6 hours who are potential candidates for endovascular thrombectomy to identify large vessel occlusions 1, 2
  • Obtain 12-lead ECG to assess cardiac rhythm and identify atrial fibrillation, but do not delay thrombolysis assessment 1, 2

Acute Ischemic Stroke Management

Intravenous Thrombolysis (Alteplase/rtPA)

Administer IV alteplase 0.9 mg/kg (maximum 90 mg total) to eligible patients as soon as possible within 3 hours of symptom onset, with treatment extending to 4.5 hours only in carefully selected patients. 1, 2

  • Give 10% of total dose as IV bolus over 1 minute, followed by 90% as continuous infusion over 60 minutes 1, 3
  • Blood pressure must be lowered to below 185/110 mmHg BEFORE rtPA administration and maintained below 180/105 mmHg for at least 24 hours AFTER treatment 1, 3, 2
  • Eligibility includes age ≥18 years, all stroke severities, patients on antiplatelet monotherapy or dual antiplatelet therapy, and end-stage renal disease patients on hemodialysis with normal aPTT 2
  • Monitor neurological status and blood pressure every 15 minutes during and for 2 hours after infusion 2

Common pitfall: Do not use IV alteplase beyond 4.5 hours from symptom onset, as this increases hemorrhagic risk without proven benefit and is associated with increased mortality. 4

Endovascular Thrombectomy (EVT)

Perform EVT with stent retrievers for patients with large vessel occlusions within 6 hours of onset, including those who received IV alteplase and those ineligible for IV alteplase. 1, 2

  • EVT should be delivered within a coordinated system with rapid neurovascular imaging access and specialized neurointerventional expertise 1

Antiplatelet Therapy

Administer oral aspirin 160-325 mg within 24-48 hours after stroke onset for patients NOT receiving thrombolysis. 1, 2

  • Critical caveat: Do not give aspirin within 24 hours of rtPA treatment 1, 2
  • Consider dual antiplatelet therapy (aspirin plus clopidogrel) for 21 days started within 24 hours for minor stroke patients to reduce early recurrence risk up to 90 days 2
  • Do not use urgent anticoagulation for acute ischemic stroke due to increased bleeding risk 3

Blood Pressure Management in Ischemic Stroke

For patients NOT receiving thrombolysis, withhold antihypertensive medications unless systolic BP >220 mmHg or diastolic BP >120 mmHg. 1, 3

  • When treating extreme elevation, reduce BP by approximately 15% (not more than 25%) over the first 24 hours 2
  • For patients receiving thrombolysis, treat BP >185/110 mmHg immediately 3, 2

Acute Hemorrhagic Stroke Management

Blood Pressure Control in Intracerebral Hemorrhage (ICH)

For ICH patients with systolic BP between 150-220 mmHg without contraindications, acutely lower systolic BP to 140 mmHg, as this is safe and may improve functional outcomes. 3

  • Assess BP immediately upon emergency department arrival and every 15 minutes until stable 3

Reversal of Coagulopathy

For patients on vitamin K antagonists with elevated INR, immediately discontinue the medication, administer therapy to replace vitamin K-dependent factors, correct INR, and give IV vitamin K. 3

  • Provide appropriate factor replacement therapy or platelets for patients with severe coagulation factor deficiency or severe thrombocytopenia 3

Management of Increased Intracranial Pressure

Perform surgical decompression and evacuation for large cerebellar infarctions causing brainstem compression and hydrocephalus. 1, 3

  • Use osmotherapy and hyperventilation for patients deteriorating from increased intracranial pressure 1, 3
  • Do not use corticosteroids for managing cerebral edema and increased intracranial pressure following ischemic stroke 1

Supportive Care (Both Stroke Types)

Airway and Oxygenation

  • Provide airway support and ventilatory assistance for patients with decreased consciousness or bulbar dysfunction 1, 3
  • Administer supplemental oxygen to maintain oxygen saturation >94% 1, 3

Temperature Management

  • Treat hyperthermia >38°C with antipyretics and identify underlying sources 1, 3

Glucose Management

  • Immediately treat hypoglycemia (blood glucose <60 mg/dL) to achieve normoglycemia 1, 3
  • Treat hyperglycemia to achieve blood glucose levels between 140-180 mg/dL 1, 3

Hydration and Nutrition

  • Correct hypovolemia with IV normal saline 1, 3
  • Perform formal dysphagia screening before initiating oral intake to reduce pneumonia risk 3, 2

Venous Thromboembolism Prophylaxis

  • Initiate intermittent pneumatic compression on day of hospital admission for patients with restricted mobility 3, 5
  • Use prophylactic low-dose subcutaneous heparin or low-molecular-weight heparin for acute stroke patients with restricted mobility 5

Early Mobilization

Begin frequent, brief out-of-bed activity within 24 hours if no contraindications to prevent complications. 1, 3, 2


Stroke Unit Care

Admit all stroke patients to a geographically defined stroke unit with specialized staff as soon as possible, ideally within 24 hours of hospital arrival. 1, 2

  • Initiate comprehensive rehabilitation as early as medically possible 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.